Supplemental Figure S2 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.

Diama Bhadra Vale
Marcus Tolentino Silva
Michelle Garcia Discacciati
Ilana Polegatto
Julio Cesar Teixeira
Luiz Carlos Zeferino

January 2021

ObjectiveTo report a modelling study using local health care costs and epidemiological inputs from a...

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

Pista, Angela
Costa, Carlos
Saldanha, Conceição
Moutinho, José Alberto Fonseca
Moutinho, José Maria
Arrobas, Fernando
Catalão, Carlos
Kempers, Jari

February 2019

Background: Primary Human Papilloma Virus (HPV) testing is the currently recommended cervical cancer...

Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia

Coupé, V. M H
Berkhof, J.
Verheijen, R. H M
Meijer, C. J L M

April 2007

Objective: To compare current cytological follow up of women treated for high-grade cervical intraep...

Supplemental Figure S1 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Figure S1 shows tornado diagrams of range of results observed in the one-way sensitivit...

Supplemental Table S2 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S2 shows the distribution of patient attributes in the prevalent US population of...

Supplemental Table S1 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S1 shows the unpublished data from the IMPACT clinical trial referenced in for th...

Supplemental Table S4 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S4 shows the top five most influential inputs based on the one-way sensitivity an...

Supplemental Table S3 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S3 shows the procedure codes, CMS fee schedule payments, and usage information us...

Cost Effectiveness of Human Papillomavirus 16/18 Genotyping in Cervical Cancer Screening

김영태

January 2015

Objectives: The aim of this study was to evaluate the cost-effectiveness of cervical cancer screenin...

Cost-effectiveness of cervical cancer screening: Cytology versus human papillomavirus DNA testing

Rosmalen, Joost
Kok, Inge
Ballegooijen, Marjolein

May 2012

Objective To determine the most cost-effective screening programme for cervical cancer. Design Cost-...

Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands

Luttjeboer, Jos
Setiawan, Didik
Cao, Qi
Daemen, Toos CAHH
Postma, Maarten J.

December 2016

In this study, the potential price for a therapeutic vaccine against Human Papilloma Virus (HPV)-16 ...

Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong

Kim, JJ
Woo, PPS
Goldie, SJ
Leung, GM

January 2004

Background: To assess the cost-effectiveness of alternative cervical cancer screening strategies to ...

Cost-effectiveness of the Conventional Papanicolaou Test With a New Adjunct to Cytological Screening for Squamous Cell Carcinoma of the Uterine Cervix and Its Precursors

Lynn A. Taylor
Mpa Sonja
V. Sorensen
Mph Nancy
F. Ray
Arch Fam Med

October 2016

Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...

Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis.

Sawaya, George F
Sanstead, Erinn
Alarid-Escudero, Fernando
Smith-McCune, Karen
Gregorich, Steven E
Silverberg, Michael J
Leyden, Wendy
Huchko, Megan J
Kuppermann, Miriam
Kulasingam, Shalini

July 2019

ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...

Cost-Effectiveness of 21 Alternative Cervical Cancer Screening Strategies

Chuck, Anderson

April 2010

ABSTRACTObjectivesThe aim of this study is to assess the cost-effectiveness of 21 alternative cervic...

Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.

Diama Bhadra Vale
Marcus Tolentino Silva
Michelle Garcia Discacciati
Ilana Polegatto
Julio Cesar Teixeira
Luiz Carlos Zeferino

January 2021

ObjectiveTo report a modelling study using local health care costs and epidemiological inputs from a...

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

Pista, Angela
Costa, Carlos
Saldanha, Conceição
Moutinho, José Alberto Fonseca
Moutinho, José Maria
Arrobas, Fernando
Catalão, Carlos
Kempers, Jari

February 2019

Background: Primary Human Papilloma Virus (HPV) testing is the currently recommended cervical cancer...

Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia

Coupé, V. M H
Berkhof, J.
Verheijen, R. H M
Meijer, C. J L M

April 2007

Objective: To compare current cytological follow up of women treated for high-grade cervical intraep...

Supplemental Figure S1 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Figure S1 shows tornado diagrams of range of results observed in the one-way sensitivit...

Supplemental Table S2 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S2 shows the distribution of patient attributes in the prevalent US population of...

Supplemental Table S1 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S1 shows the unpublished data from the IMPACT clinical trial referenced in for th...

Supplemental Table S4 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S4 shows the top five most influential inputs based on the one-way sensitivity an...

Supplemental Table S3 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Diane M. Harper (16426297)
Rye J. Anderson (16426300)
Ed Baker (16426303)
Tiffany M. Yu (16426306)

July 2023

Supplemental Table S3 shows the procedure codes, CMS fee schedule payments, and usage information us...

Cost Effectiveness of Human Papillomavirus 16/18 Genotyping in Cervical Cancer Screening

김영태

January 2015

Objectives: The aim of this study was to evaluate the cost-effectiveness of cervical cancer screenin...

Cost-effectiveness of cervical cancer screening: Cytology versus human papillomavirus DNA testing

Rosmalen, Joost
Kok, Inge
Ballegooijen, Marjolein

May 2012

Objective To determine the most cost-effective screening programme for cervical cancer. Design Cost-...

Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands

Luttjeboer, Jos
Setiawan, Didik
Cao, Qi
Daemen, Toos CAHH
Postma, Maarten J.

December 2016

In this study, the potential price for a therapeutic vaccine against Human Papilloma Virus (HPV)-16 ...

Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong

Kim, JJ
Woo, PPS
Goldie, SJ
Leung, GM

January 2004

Background: To assess the cost-effectiveness of alternative cervical cancer screening strategies to ...

Cost-effectiveness of the Conventional Papanicolaou Test With a New Adjunct to Cytological Screening for Squamous Cell Carcinoma of the Uterine Cervix and Its Precursors

Lynn A. Taylor
Mpa Sonja
V. Sorensen
Mph Nancy
F. Ray
Arch Fam Med

October 2016

Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...

Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis.

Sawaya, George F
Sanstead, Erinn
Alarid-Escudero, Fernando
Smith-McCune, Karen
Gregorich, Steven E
Silverberg, Michael J
Leyden, Wendy
Huchko, Megan J
Kuppermann, Miriam
Kulasingam, Shalini

July 2019

ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...

Cost-Effectiveness of 21 Alternative Cervical Cancer Screening Strategies

Chuck, Anderson

April 2010

ABSTRACTObjectivesThe aim of this study is to assess the cost-effectiveness of 21 alternative cervic...

Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.

Diama Bhadra Vale
Marcus Tolentino Silva
Michelle Garcia Discacciati
Ilana Polegatto
Julio Cesar Teixeira
Luiz Carlos Zeferino

January 2021

ObjectiveTo report a modelling study using local health care costs and epidemiological inputs from a...

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

Pista, Angela
Costa, Carlos
Saldanha, Conceição
Moutinho, José Alberto Fonseca
Moutinho, José Maria
Arrobas, Fernando
Catalão, Carlos
Kempers, Jari

February 2019

Background: Primary Human Papilloma Virus (HPV) testing is the currently recommended cervical cancer...

Cost-effectiveness of human papillomavirus testing after treatment for cervical intraepithelial neoplasia

Coupé, V. M H
Berkhof, J.
Verheijen, R. H M
Meijer, C. J L M

April 2007

Objective: To compare current cytological follow up of women treated for high-grade cervical intraep...

Supplemental Figure S2 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Abstract

Extracted data

Supplemental Figure S2 from Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening

Abstract

Extracted data

Related items

Related items